Commentary: The Alzheimer's mistake by the FDA is already getting worse
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence. |!| Portland
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence. |!| Portland